Virtu (VIRT) Q3 2026 Earnings Call Transcript

Virtu Financial reported Q3 2026 revenue of $1,153.9 million, up 39.9% year over year, and net trading income of $820.2 million, up 55.0%; normalized adjusted EPS rose to $1.77 from $1.05. Adjusted EBITDA was $437.9 million with a 62.2% margin, while trailing 12-month ANT per day, adjusted EBITDA and normalized adjusted EPS reached company records of $11.3 million, $1.8 billion and $7.69, respectively. Virtu raised $500 million in debt, bringing trading capital to $3.4 billion, and maintained its quarterly dividend at $0.24 per share; management said activity eased sequentially but remained above historical averages.

Analysis

Analysis The key question is whether recent earnings power is becoming less dependent on U.S. equity activity—or merely more exposed to episodic offshore and crypto bursts. If the mix shift persists, it could lower the sensitivity of ANT to conventional volume/volatility indicators and support a higher through-cycle valuation. But one quarter does not establish that diversification: track segment-level ANT and daily P&L dispersion across quieter markets.

The less appreciated risk is capital productivity. Added debt expands deployable capacity, but slower markets can leave more capital earning less while interest expense, technology investment, and hiring continue. That creates downside operating leverage after an unusually strong trailing period. Wider P&L dispersion also matters: a few adverse trading episodes could pressure earnings and confidence even if average profitability remains high. The Texas redomestication appears operationally neutral in the stated plan; it is not an earnings catalyst absent evidence of changed costs or regulation.

Horizon: Near term, results may reinforce momentum, but chasing a record run-rate risks buying peak-cycle earnings. Over 1–3 months, watch ANT through softer activity, expense growth, and whether capital deployment sustains returns. Over 6–18 months, the thesis depends on durable non-U.S./new-product contribution and technology spend translating into scale rather than simply a higher cost base. Falsification: a persistent decline in ANT per day alongside rising expenses, or weaker returns as capital grows.

Contrarian view: The market may over-credit a single strong quarter as proof of lower cyclicality. Conversely, treating Virtu as only a U.S. equity-volume proxy may understate the value of its broader trading mix and client execution franchise.

Key Decisions for Investors

• Do not chase VIRT solely on record trailing results. Consider a measured long on a pullback only if subsequent updates show ANT holding up as market activity normalizes; reassess if daily ANT trends down while operating expenses keep rising.
• For the next 1–3 months, monitor segment-level ANT, daily P&L dispersion, capital deployment, and debt/interest expense. These are more useful thesis tests than headline revenue growth; request clarification if reported figures are not reconciled across company materials.
• Treat the $4 billion-plus capital ambition as conditional, not automatically accretive. Favor growth in capital only if management demonstrates that incremental capacity can be deployed with buffers while maintaining attractive profitability.
• No options trade is warranted from this transcript alone: current share price, implied volatility, and expectations are not supplied. Revisit after comparing the market reaction with forward ANT and expense guidance.